Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berger, J. R.
Right arrow Articles by Kelley, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berger, J. R.
Right arrow Articles by Kelley, R. E.
NEUROLOGY 1981;31:93
© 1981 American Academy of Neurology

Thyroid function in Parkinson disease

Joseph R. Berger, M.D. and Roger E. Kelley, M.D.

From the Department of Neurology, University of Miami School of Medicine, Miami, FL

We conducted a prospective study of thyroid function in 46 patients with Parkinson disease and 46 age- and sex-matched controls with other neurologic disease. There was no statistical difference in serum thyroxine (T4) and T3 resin uptake (T3U) between the two groups. Neither the duration nor the quantity of L-dopa or carbidopabdopa (Sinemet) therapy influenced these assessments of thyroid function. However, 3 of 46 Parkinson patients were hypothyroid, whereas none of 46 controls was hypothyroid. There was one hyperthyroid individual in each group. Early evaluation of thyroid function in all patients with Parkinson disease is recommended because of the unexpected frequency of hypothyroidism and because hypothyroid symptoms may be masked.

Address correspondence and reprint requests to Dr. Berger, Department of Neurology, University of Miami School of Medicine (D4-51, P.O. Box 016960, Miami, FL 33101.

Accepted for publication March 20, 1980.




This article has been cited by other articles:


Home page
Arch NeurolHome page
M. S. Okun, W. M. McDonald, and M. R. DeLong
Refractory Nonmotor Symptoms in Male Patients With Parkinson Disease Due to Testosterone Deficiency: A Common Unrecognized Comorbidity
Arch Neurol, May 1, 2002; 59(5): 807 - 811.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. S. Okun and R. L. Watts
Depression associated with Parkinson's disease: Clinical features and treatment
Neurology, February 1, 2002; 58(90001): S63 - 70.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by AAN Enterprises, Inc.